+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Enzymes for Drug Synthesis Market - Global Forecast 2026-2032- Product Image
Enzymes for Drug Synthesis Market - Global Forecast 2026-2032- Product Image
Sale

Enzymes for Drug Synthesis Market - Global Forecast 2026-2032

  • Report

  • 189 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6121950
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Enzymes for Drug Synthesis Market is projected to reach USD 7.37 Billion in 2026. It is expected to continue growing at a CAGR of 5.25%, reaching USD 10.08 Billion by 2032.

Enzymes for Drug Synthesis: Executive Summary

Enzymes for drug synthesis are biological catalysts used to create, modify, or resolve pharmaceutical intermediates and active ingredients. Their value proposition is grounded in high selectivity, operation under comparatively mild conditions, and the ability to support more efficient synthetic routes. Adoption is shaped by process performance, regulatory acceptance, supply reliability, enzyme engineering capability, and compatibility with established pharmaceutical manufacturing systems.

Biocatalysis Is Reshaping Pharmaceutical Manufacturing

The landscape is shifting from isolated laboratory applications toward integrated biocatalytic process design. Advances in directed evolution, immobilization, continuous processing, and reaction engineering are improving enzyme robustness and enabling broader substrate compatibility. At the same time, pharmaceutical producers are placing greater emphasis on greener chemistry, lower waste generation, reduced solvent intensity, and streamlined routes to complex molecules. These priorities are encouraging closer collaboration among drug developers, contract manufacturers, enzyme specialists, and academic researchers.

Artificial Intelligence Accelerates Enzyme Discovery and Process Optimization

Artificial intelligence is contributing across the enzyme-development workflow by helping researchers identify promising sequences, predict structure-function relationships, prioritize mutations, and optimize reaction conditions. Machine-learning models can also support substrate-scope assessment, immobilization design, and process-control decisions when trained on reliable experimental data. The principal constraints remain data quality, limited representation of unusual substrates, explainability requirements, and the need for laboratory validation. In practice, AI is most effective when combined with high-throughput experimentation, automation, and expert process chemistry.

Regional Dynamics Reflect Different Manufacturing and Innovation Strengths

North America combines advanced pharmaceutical research, biotechnology infrastructure, and established process-development capabilities. Europe benefits from strong green-chemistry priorities, sophisticated pharmaceutical manufacturing, and coordinated research networks. Asia-Pacific is supported by expanding pharmaceutical production, biotechnology investment, and growing capabilities in enzyme engineering and contract development. Latin America is developing biopharmaceutical and generic-drug manufacturing capacity, while adoption is influenced by technology access and supply-chain resilience. The Middle East is pursuing industrial diversification and life-science development, and Africa’s progress is linked to laboratory infrastructure, skills development, local manufacturing initiatives, and partnerships with international institutions.

Economic and Strategic Groups Shape Collaboration and Supply Resilience

ASEAN economies are strengthening pharmaceutical and biotechnology links through regional manufacturing networks and investment in technical capabilities. BRICS members span major research, production, and raw-material ecosystems, creating opportunities for technology cooperation while retaining differences in regulation and infrastructure. The European Union emphasizes harmonized standards, sustainability, and advanced manufacturing. G7 economies remain influential in pharmaceutical innovation, quality systems, and high-value process development. GCC countries are expanding life-science strategies and manufacturing diversification, and NATO members benefit from extensive scientific, industrial, and supply-chain relationships relevant to pharmaceutical production.

Country-Level Capabilities Vary Across Innovation, Manufacturing, and Regulation

Australia contributes strong research institutions and biotechnology expertise. Brazil and Mexico are important Latin American pharmaceutical and manufacturing environments, with continued attention to local production and technology transfer. Canada supports bioprocess research and advanced life-science development. China and India combine substantial pharmaceutical manufacturing capacity with expanding enzyme-engineering capabilities. France, Germany, Italy, Spain, and the United Kingdom contribute established research, regulatory, and process-development strengths within Europe. Japan and South Korea offer advanced chemical, pharmaceutical, and biotechnology infrastructure. Russia retains scientific and industrial capabilities, although market access, collaboration conditions, and supply-chain constraints affect deployment. The United States remains a major center for pharmaceutical innovation, bioprocess development, and commercialization.

Industry Leaders Should Prioritize Validated, Scalable Biocatalytic Platforms

Leaders should evaluate enzymes against total process economics, including yield, selectivity, cycle time, solvent use, waste, purification, and downstream integration. Investment priorities should include enzyme engineering, immobilization, reusable catalyst systems, and continuous or intensified processing where technically justified. Organizations should build cross-functional teams linking medicinal chemistry, process chemistry, biochemical engineering, analytics, quality, and regulatory affairs. They should also establish data standards for AI development, validate model outputs experimentally, diversify critical suppliers, and qualify alternative production routes before scale-up. Early engagement with regulators and manufacturing partners can reduce technology-transfer and commercialization risks.

Methodology: Evidence-Led Synthesis of Technology and Industry Signals

This executive summary uses the defined scope of enzymes for drug synthesis and organizes verified, non-estimative insights around technology development, manufacturing practice, sustainability, artificial intelligence, geography, and institutional groupings. The assessment distinguishes established capabilities from emerging applications and considers adoption factors such as process performance, regulatory expectations, infrastructure, skills, and supply-chain resilience. Regional, group, and country observations are presented qualitatively; no market estimates, market shares, forecasts, or company-specific claims are included.

Enzymes Are Becoming a Strategic Tool for Efficient Drug Production

Enzymatic synthesis is increasingly relevant to pharmaceutical organizations seeking selective, resource-efficient, and scalable routes to complex molecules. Progress will depend on translating enzyme discovery into reproducible manufacturing performance, supported by robust analytics, sound regulatory strategies, reliable supply networks, and disciplined process validation. Artificial intelligence can accelerate this transition, but experimental evidence and engineering execution remain decisive. Companies that integrate biocatalysis into broader process-development portfolios will be better positioned to pursue cleaner chemistry and operational resilience.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Enzymes for Drug Synthesis Market, by Enzyme Type
7.1. Introduction
7.2. Hydrolase
7.2.1. Esterase
7.2.2. Glycosidase
7.2.3. Lipase
7.2.4. Protease
7.2.4.1. Aspartic Protease
7.2.4.2. Cysteine Protease
7.2.4.3. Metalloprotease
7.2.4.4. Serine Protease
7.3. Isomerase
7.4. Ligase
7.5. Lyase
7.6. Oxidoreductase
7.6.1. Dehydrogenase
7.6.2. Oxidase
7.6.3. Oxygenase
7.6.4. Reductase
7.7. Transferase
7.7.1. Aminotransferase
7.7.2. Glycosyltransferase
7.7.3. Methyltransferase
7.7.4. Phosphotransferase
8. Enzymes for Drug Synthesis Market, by Source
8.1. Introduction
8.2. Animal
8.3. Microbial
8.4. Plant
8.5. Recombinant
8.5.1. E Coli Expression Systems
8.5.2. Fungal Expression Systems
8.5.3. Yeast Expression Systems
9. Enzymes for Drug Synthesis Market, by Process Type
9.1. Introduction
9.2. Free Enzyme
9.3. Immobilized Enzyme
9.3.1. Carrier Bound
9.3.2. Cross Linked
10. Enzymes for Drug Synthesis Market, by Product Form
10.1. Introduction
10.2. Liquid Form
10.3. Solid Form
11. Enzymes for Drug Synthesis Market, by Application
11.1. Introduction
11.2. Biocatalysis
11.3. Chiral Resolution
11.4. Fermentation
11.5. Precursor Synthesis
12. Enzymes for Drug Synthesis Market, by End User
12.1. Introduction
12.2. Academic Institutes
12.3. Biotechnology Companies
12.4. Contract Research Organizations
12.5. Pharmaceutical Companies
13. Enzymes for Drug Synthesis Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Enzymes for Drug Synthesis Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Enzymes for Drug Synthesis Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. AB Enzymes GmbH
17.2. ALLOYZMES Pte Ltd.
17.3. Amano Enzyme Inc.
17.4. BASF SE
17.5. Biomatter Inc.
17.6. Codexis, Inc.
17.7. DuPont de Nemours, Inc.
17.8. Evonik Industries AG
17.9. GenScript Biotech Corporation
17.10. Lonza Group AG
17.11. Novozymes A/S
17.12. Promega Corporation
17.13. Royal DSM N.V.
17.14. Takara Bio Inc.
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Enzymes for Drug Synthesis Market, Years Considered for the Study
FIGURE 2. Global Enzymes for Drug Synthesis Market, Research Design
FIGURE 3. Global Enzymes for Drug Synthesis Market, Research Framework
FIGURE 4. Global Enzymes for Drug Synthesis Market, Data Triangulation
FIGURE 5. Global Enzymes for Drug Synthesis Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Enzymes for Drug Synthesis Market Size, by Enzyme Type, 2025 vs 2032 (%)
FIGURE 7. Global Enzymes for Drug Synthesis Market Size, by Enzyme Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Enzymes for Drug Synthesis Market Size, by Source, 2025 vs 2032 (%)
FIGURE 9. Global Enzymes for Drug Synthesis Market Size, by Source, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Enzymes for Drug Synthesis Market Size, by Process Type, 2025 vs 2032 (%)
FIGURE 11. Global Enzymes for Drug Synthesis Market Size, by Process Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Enzymes for Drug Synthesis Market Size, by Product Form, 2025 vs 2032 (%)
FIGURE 13. Global Enzymes for Drug Synthesis Market Size, by Product Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Enzymes for Drug Synthesis Market Size, by Application, 2025 vs 2032 (%)
FIGURE 15. Global Enzymes for Drug Synthesis Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Enzymes for Drug Synthesis Market Size, by End User, 2025 vs 2032 (%)
FIGURE 17. Global Enzymes for Drug Synthesis Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Enzymes for Drug Synthesis Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Enzymes for Drug Synthesis Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Enzymes for Drug Synthesis Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Enzymes for Drug Synthesis Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Enzymes for Drug Synthesis Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Enzymes for Drug Synthesis Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Enzymes for Drug Synthesis Market Segmentation & Coverage
TABLE 2. Global Enzymes for Drug Synthesis Market Size, 2017-2032 (USD Million)
TABLE 3. Global Enzymes for Drug Synthesis Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 4. Global Hydrolase Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Hydrolase Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Hydrolase Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Esterase Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Esterase Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Esterase Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Glycosidase Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Glycosidase Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Glycosidase Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Lipase Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Lipase Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Lipase Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Protease Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Protease Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Protease Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Aspartic Protease Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Aspartic Protease Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Aspartic Protease Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Cysteine Protease Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Cysteine Protease Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Cysteine Protease Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Metalloprotease Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Metalloprotease Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Metalloprotease Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Serine Protease Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Serine Protease Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Serine Protease Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Isomerase Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Isomerase Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Isomerase Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Ligase Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Ligase Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Ligase Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Lyase Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Lyase Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Lyase Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Oxidoreductase Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Oxidoreductase Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Oxidoreductase Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Dehydrogenase Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Dehydrogenase Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Dehydrogenase Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Oxidase Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Oxidase Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Oxidase Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Oxygenase Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Oxygenase Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Oxygenase Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Reductase Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Reductase Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Reductase Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Transferase Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Transferase Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Transferase Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Aminotransferase Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Aminotransferase Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Aminotransferase Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Glycosyltransferase Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Glycosyltransferase Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Glycosyltransferase Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Methyltransferase Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Methyltransferase Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Methyltransferase Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Phosphotransferase Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Phosphotransferase Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Phosphotransferase Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Enzymes for Drug Synthesis Market Size, by Source, 2017-2032 (USD Million)
TABLE 71. Global Animal Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Animal Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Animal Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Microbial Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Microbial Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Microbial Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Plant Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Plant Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Plant Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Recombinant Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Recombinant Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Recombinant Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global E Coli Expression Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global E Coli Expression Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global E Coli Expression Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Fungal Expression Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Fungal Expression Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Fungal Expression Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Yeast Expression Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Yeast Expression Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Yeast Expression Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Enzymes for Drug Synthesis Market Size, by Process Type, 2017-2032 (USD Million)
TABLE 93. Global Free Enzyme Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Free Enzyme Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Free Enzyme Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Immobilized Enzyme Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Global Immobilized Enzyme Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. Global Immobilized Enzyme Market Size, by Country, 2017-2032 (USD Million)
TABLE 99. Global Carrier Bound Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Global Carrier Bound Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. Global Carrier Bound Market Size, by Country, 2017-2032 (USD Million)
TABLE 102. Global Cross Linked Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Global Cross Linked Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. Global Cross Linked Market Size, by Country, 2017-2032 (USD Million)
TABLE 105. Global Enzymes for Drug Synthesis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 106. Global Liquid Form Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Liquid Form Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Liquid Form Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Solid Form Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Solid Form Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Solid Form Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Enzymes for Drug Synthesis Market Size, by Application, 2017-2032 (USD Million)
TABLE 113. Global Biocatalysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Global Biocatalysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. Global Biocatalysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. Global Chiral Resolution Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Global Chiral Resolution Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. Global Chiral Resolution Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. Global Fermentation Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Global Fermentation Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. Global Fermentation Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. Global Precursor Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Global Precursor Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. Global Precursor Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 125. Global Enzymes for Drug Synthesis Market Size, by End User, 2017-2032 (USD Million)
TABLE 126. Global Academic Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 127. Global Academic Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. Global Academic Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 129. Global Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 130. Global Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. Global Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 132. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 133. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 135. Global Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 136. Global Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. Global Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 138. Global Enzymes for Drug Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 139. Asia-Pacific Enzymes for Drug Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 140. Asia-Pacific Enzymes for Drug Synthesis Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 141. Asia-Pacific Enzymes for Drug Synthesis Market Size, by Hydrolase, 2017-2032 (USD Million)
TABLE 142. Asia-Pacific Enzymes for Drug Synthesis Market Size, by Protease, 2017-2032 (USD Million)
TABLE 143. Asia-Pacific Enzymes for Drug Synthesis Market Size, by Oxidoreductase, 2017-2032 (USD Million)
TABLE 144. Asia-Pacific Enzymes for Drug Synthesis Market Size, by Transferase, 2017-2032 (USD Million)
TABLE 145. Asia-Pacific Enzymes for Drug Synthesis Market Size, by Source, 2017-2032 (USD Million)
TABLE 146. Asia-Pacific Enzymes for Drug Synthesis Market Size, by Recombinant, 2017-2032 (USD Million)
TABLE 147. Asia-Pacific Enzymes for Drug Synthesis Market Size, by Process Type, 2017-2032 (USD Million)
TABLE 148. Asia-Pacific Enzymes for Drug Synthesis Market Size, by Immobilized Enzyme, 2017-2032 (USD Million)
TABLE 149. Asia-Pacific Enzymes for Drug Synthesis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 150. Asia-Pacific Enzymes for Drug Synthesis Market Size, by Application, 2017-2032 (USD Million)
TABLE 151. Asia-Pacific Enzymes for Drug Synthesis Market Size, by End User, 2017-2032 (USD Million)
TABLE 152. North America Enzymes for Drug Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 153. North America Enzymes for Drug Synthesis Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 154. North America Enzymes for Drug Synthesis Market Size, by Hydrolase, 2017-2032 (USD Million)
TABLE 155. North America Enzymes for Drug Synthesis Market Size, by Protease, 2017-2032 (USD Million)
TABLE 156. North America Enzymes for Drug Synthesis Market Size, by Oxidoreductase, 2017-2032 (USD Million)
TABLE 157. North America Enzymes for Drug Synthesis Market Size, by Transferase, 2017-2032 (USD Million)
TABLE 158. North America Enzymes for Drug Synthesis Market Size, by Source, 2017-2032 (USD Million)
TABLE 159. North America Enzymes for Drug Synthesis Market Size, by Recombinant, 2017-2032 (USD Million)
TABLE 160. North America Enzymes for Drug Synthesis Market Size, by Process Type, 2017-2032 (USD Million)
TABLE 161. North America Enzymes for Drug Synthesis Market Size, by Immobilized Enzyme, 2017-2032 (USD Million)
TABLE 162. North America Enzymes for Drug Synthesis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 163. North America Enzymes for Drug Synthesis Market Size, by Application, 2017-2032 (USD Million)
TABLE 164. North America Enzymes for Drug Synthesis Market Size, by End User, 2017-2032 (USD Million)
TABLE 165. Latin America Enzymes for Drug Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 166. Latin America Enzymes for Drug Synthesis Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 167. Latin America Enzymes for Drug Synthesis Market Size, by Hydrolase, 2017-2032 (USD Million)
TABLE 168. Latin America Enzymes for Drug Synthesis Market Size, by Protease, 2017-2032 (USD Million)
TABLE 169. Latin America Enzymes for Drug Synthesis Market Size, by Oxidoreductase, 2017-2032 (USD Million)
TABLE 170. Latin America Enzymes for Drug Synthesis Market Size, by Transferase, 2017-2032 (USD Million)
TABLE 171. Latin America Enzymes for Drug Synthesis Market Size, by Source, 2017-2032 (USD Million)
TABLE 172. Latin America Enzymes for Drug Synthesis Market Size, by Recombinant, 2017-2032 (USD Million)
TABLE 173. Latin America Enzymes for Drug Synthesis Market Size, by Process Type, 2017-2032 (USD Million)
TABLE 174. Latin America Enzymes for Drug Synthesis Market Size, by Immobilized Enzyme, 2017-2032 (USD Million)
TABLE 175. Latin America Enzymes for Drug Synthesis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 176. Latin America Enzymes for Drug Synthesis Market Size, by Application, 2017-2032 (USD Million)
TABLE 177. Latin America Enzymes for Drug Synthesis Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. Europe Enzymes for Drug Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 179. Europe Enzymes for Drug Synthesis Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 180. Europe Enzymes for Drug Synthesis Market Size, by Hydrolase, 2017-2032 (USD Million)
TABLE 181. Europe Enzymes for Drug Synthesis Market Size, by Protease, 2017-2032 (USD Million)
TABLE 182. Europe Enzymes for Drug Synthesis Market Size, by Oxidoreductase, 2017-2032 (USD Million)
TABLE 183. Europe Enzymes for Drug Synthesis Market Size, by Transferase, 2017-2032 (USD Million)
TABLE 184. Europe Enzymes for Drug Synthesis Market Size, by Source, 2017-2032 (USD Million)
TABLE 185. Europe Enzymes for Drug Synthesis Market Size, by Recombinant, 2017-2032 (USD Million)
TABLE 186. Europe Enzymes for Drug Synthesis Market Size, by Process Type, 2017-2032 (USD Million)
TABLE 187. Europe Enzymes for Drug Synthesis Market Size, by Immobilized Enzyme, 2017-2032 (USD Million)
TABLE 188. Europe Enzymes for Drug Synthesis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 189. Europe Enzymes for Drug Synthesis Market Size, by Application, 2017-2032 (USD Million)
TABLE 190. Europe Enzymes for Drug Synthesis Market Size, by End User, 2017-2032 (USD Million)
TABLE 191. Middle East Enzymes for Drug Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 192. Middle East Enzymes for Drug Synthesis Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 193. Middle East Enzymes for Drug Synthesis Market Size, by Hydrolase, 2017-2032 (USD Million)
TABLE 194. Middle East Enzymes for Drug Synthesis Market Size, by Protease, 2017-2032 (USD Million)
TABLE 195. Middle East Enzymes for Drug Synthesis Market Size, by Oxidoreductase, 2017-2032 (USD Million)
TABLE 196. Middle East Enzymes for Drug Synthesis Market Size, by Transferase, 2017-2032 (USD Million)
TABLE 197. Middle East Enzymes for Drug Synthesis Market Size, by Source, 2017-2032 (USD Million)
TABLE 198. Middle East Enzymes for Drug Synthesis Market Size, by Recombinant, 2017-2032 (USD Million)
TABLE 199. Middle East Enzymes for Drug Synthesis Market Size, by Process Type, 2017-2032 (USD Million)
TABLE 200. Middle East Enzymes for Drug Synthesis Market Size, by Immobilized Enzyme, 2017-2032 (USD Million)
TABLE 201. Middle East Enzymes for Drug Synthesis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 202. Middle East Enzymes for Drug Synthesis Market Size, by Application, 2017-2032 (USD Million)
TABLE 203. Middle East Enzymes for Drug Synthesis Market Size, by End User, 2017-2032 (USD Million)
TABLE 204. Africa Enzymes for Drug Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 205. Africa Enzymes for Drug Synthesis Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 206. Africa Enzymes for Drug Synthesis Market Size, by Hydrolase, 2017-2032 (USD Million)
TABLE 207. Africa Enzymes for Drug Synthesis Market Size, by Protease, 2017-2032 (USD Million)
TABLE 208. Africa Enzymes for Drug Synthesis Market Size, by Oxidoreductase, 2017-2032 (USD Million)
TABLE 209. Africa Enzymes for Drug Synthesis Market Size, by Transferase, 2017-2032 (USD Million)
TABLE 210. Africa Enzymes for Drug Synthesis Market Size, by Source, 2017-2032 (USD Million)
TABLE 211. Africa Enzymes for Drug Synthesis Market Size, by Recombinant, 2017-2032 (USD Million)
TABLE 212. Africa Enzymes for Drug Synthesis Market Size, by Process Type, 2017-2032 (USD Million)
TABLE 213. Africa Enzymes for Drug Synthesis Market Size, by Immobilized Enzyme, 2017-2032 (USD Million)
TABLE 214. Africa Enzymes for Drug Synthesis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 215. Africa Enzymes for Drug Synthesis Market Size, by Application, 2017-2032 (USD Million)
TABLE 216. Africa Enzymes for Drug Synthesis Market Size, by End User, 2017-2032 (USD Million)
TABLE 217. Global Enzymes for Drug Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 218. ASEAN Enzymes for Drug Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 219. ASEAN Enzymes for Drug Synthesis Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 220. ASEAN Enzymes for Drug Synthesis Market Size, by Hydrolase, 2017-2032 (USD Million)
TABLE 221. ASEAN Enzymes for Drug Synthesis Market Size, by Protease, 2017-2032 (USD Million)
TABLE 222. ASEAN Enzymes for Drug Synthesis Market Size, by Oxidoreductase, 2017-2032 (USD Million)
TABLE 223. ASEAN Enzymes for Drug Synthesis Market Size, by Transferase, 2017-2032 (USD Million)
TABLE 224. ASEAN Enzymes for Drug Synthesis Market Size, by Source, 2017-2032 (USD Million)
TABLE 225. ASEAN Enzymes for Drug Synthesis Market Size, by Recombinant, 2017-2032 (USD Million)
TABLE 226. ASEAN Enzymes for Drug Synthesis Market Size, by Process Type, 2017-2032 (USD Million)
TABLE 227. ASEAN Enzymes for Drug Synthesis Market Size, by Immobilized Enzyme, 2017-2032 (USD Million)
TABLE 228. ASEAN Enzymes for Drug Synthesis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 229. ASEAN Enzymes for Drug Synthesis Market Size, by Application, 2017-2032 (USD Million)
TABLE 230. ASEAN Enzymes for Drug Synthesis Market Size, by End User, 2017-2032 (USD Million)
TABLE 231. GCC Enzymes for Drug Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 232. GCC Enzymes for Drug Synthesis Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 233. GCC Enzymes for Drug Synthesis Market Size, by Hydrolase, 2017-2032 (USD Million)
TABLE 234. GCC Enzymes for Drug Synthesis Market Size, by Protease, 2017-2032 (USD Million)
TABLE 235. GCC Enzymes for Drug Synthesis Market Size, by Oxidoreductase, 2017-2032 (USD Million)
TABLE 236. GCC Enzymes for Drug Synthesis Market Size, by Transferase, 2017-2032 (USD Million)
TABLE 237. GCC Enzymes for Drug Synthesis Market Size, by Source, 2017-2032 (USD Million)
TABLE 238. GCC Enzymes for Drug Synthesis Market Size, by Recombinant, 2017-2032 (USD Million)
TABLE 239. GCC Enzymes for Drug Synthesis Market Size, by Process Type, 2017-2032 (USD Million)
TABLE 240. GCC Enzymes for Drug Synthesis Market Size, by Immobilized Enzyme, 2017-2032 (USD Million)
TABLE 241. GCC Enzymes for Drug Synthesis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 242. GCC Enzymes for Drug Synthesis Market Size, by Application, 2017-2032 (USD Million)
TABLE 243. GCC Enzymes for Drug Synthesis Market Size, by End User, 2017-2032 (USD Million)
TABLE 244. European Union Enzymes for Drug Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 245. European Union Enzymes for Drug Synthesis Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 246. European Union Enzymes for Drug Synthesis Market Size, by Hydrolase, 2017-2032 (USD Million)
TABLE 247. European Union Enzymes for Drug Synthesis Market Size, by Protease, 2017-2032 (USD Million)
TABLE 248. European Union Enzymes for Drug Synthesis Market Size, by Oxidoreductase, 2017-2032 (USD Million)
TABLE 249. European Union Enzymes for Drug Synthesis Market Size, by Transferase, 2017-2032 (USD Million)
TABLE 250. European Union Enzymes for Drug Synthesis Market Size, by Source, 2017-2032 (USD Million)
TABLE 251. European Union Enzymes for Drug Synthesis Market Size, by Recombinant, 2017-2032 (USD Million)
TABLE 252. European Union Enzymes for Drug Synthesis Market Size, by Process Type, 2017-2032 (USD Million)
TABLE 253. European Union Enzymes for Drug Synthesis Market Size, by Immobilized Enzyme, 2017-2032 (USD Million)
TABLE 254. European Union Enzymes for Drug Synthesis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 255. European Union Enzymes for Drug Synthesis Market Size, by Application, 2017-2032 (USD Million)
TABLE 256. European Union Enzymes for Drug Synthesis Market Size, by End User, 2017-2032 (USD Million)
TABLE 257. BRICS Enzymes for Drug Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 258. BRICS Enzymes for Drug Synthesis Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 259. BRICS Enzymes for Drug Synthesis Market Size, by Hydrolase, 2017-2032 (USD Million)
TABLE 260. BRICS Enzymes for Drug Synthesis Market Size, by Protease, 2017-2032 (USD Million)
TABLE 261. BRICS Enzymes for Drug Synthesis Market Size, by Oxidoreductase, 2017-2032 (USD Million)
TABLE 262. BRICS Enzymes for Drug Synthesis Market Size, by Transferase, 2017-2032 (USD Million)
TABLE 263. BRICS Enzymes for Drug Synthesis Market Size, by Source, 2017-2032 (USD Million)
TABLE 264. BRICS Enzymes for Drug Synthesis Market Size, by Recombinant, 2017-2032 (USD Million)
TABLE 265. BRICS Enzymes for Drug Synthesis Market Size, by Process Type, 2017-2032 (USD Million)
TABLE 266. BRICS Enzymes for Drug Synthesis Market Size, by Immobilized Enzyme, 2017-2032 (USD Million)
TABLE 267. BRICS Enzymes for Drug Synthesis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 268. BRICS Enzymes for Drug Synthesis Market Size, by Application, 2017-2032 (USD Million)
TABLE 269. BRICS Enzymes for Drug Synthesis Market Size, by End User, 2017-2032 (USD Million)
TABLE 270. G7 Enzymes for Drug Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 271. G7 Enzymes for Drug Synthesis Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 272. G7 Enzymes for Drug Synthesis Market Size, by Hydrolase, 2017-2032 (USD Million)
TABLE 273. G7 Enzymes for Drug Synthesis Market Size, by Protease, 2017-2032 (USD Million)
TABLE 274. G7 Enzymes for Drug Synthesis Market Size, by Oxidoreductase, 2017-2032 (USD Million)
TABLE 275. G7 Enzymes for Drug Synthesis Market Size, by Transferase, 2017-2032 (USD Million)
TABLE 276. G7 Enzymes for Drug Synthesis Market Size, by Source, 2017-2032 (USD Million)
TABLE 277. G7 Enzymes for Drug Synthesis Market Size, by Recombinant, 2017-2032 (USD Million)
TABLE 278. G7 Enzymes for Drug Synthesis Market Size, by Process Type, 2017-2032 (USD Million)
TABLE 279. G7 Enzymes for Drug Synthesis Market Size, by Immobilized Enzyme, 2017-2032 (USD Million)
TABLE 280. G7 Enzymes for Drug Synthesis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 281. G7 Enzymes for Drug Synthesis Market Size, by Application, 2017-2032 (USD Million)
TABLE 282. G7 Enzymes for Drug Synthesis Market Size, by End User, 2017-2032 (USD Million)
TABLE 283. NATO Enzymes for Drug Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 284. NATO Enzymes for Drug Synthesis Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 285. NATO Enzymes for Drug Synthesis Market Size, by Hydrolase, 2017-2032 (USD Million)
TABLE 286. NATO Enzymes for Drug Synthesis Market Size, by Protease, 2017-2032 (USD Million)
TABLE 287. NATO Enzymes for Drug Synthesis Market Size, by Oxidoreductase, 2017-2032 (USD Million)
TABLE 288. NATO Enzymes for Drug Synthesis Market Size, by Transferase, 2017-2032 (USD Million)
TABLE 289. NATO Enzymes for Drug Synthesis Market Size, by Source, 2017-2032 (USD Million)
TABLE 290. NATO Enzymes for Drug Synthesis Market Size, by Recombinant, 2017-2032 (USD Million)
TABLE 291. NATO Enzymes for Drug Synthesis Market Size, by Process Type, 2017-2032 (USD Million)
TABLE 292. NATO Enzymes for Drug Synthesis Market Size, by Immobilized Enzyme, 2017-2032 (USD Million)
TABLE 293. NATO Enzymes for Drug Synthesis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 294. NATO Enzymes for Drug Synthesis Market Size, by Application, 2017-2032 (USD Million)
TABLE 295. NATO Enzymes for Drug Synthesis Market Size, by End User, 2017-2032 (USD Million)
TABLE 296. Global Enzymes for Drug Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 297. United States Enzymes for Drug Synthesis Market Size, 2017-2032 (USD Million)
TABLE 298. United States Enzymes for Drug Synthesis Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 299. United States Enzymes for Drug Synthesis Market Size, by Hydrolase, 2017-2032 (USD Million)
TABLE 300. United States Enzymes for Drug Synthesis Market Size, by Protease, 2017-2032 (USD Million)
TABLE 301. United States Enzymes for Drug Synthesis Market Size, by Oxidoreductase, 2017-2032 (USD Million)
TABLE 302. United States Enzymes for Drug Synthesis Market Size, by Transferase, 2017-2032 (USD Million)
TABLE 303. United States Enzymes for Drug Synthesis Market Size, by Source, 2017-2032 (USD Million)
TABLE 304. United States Enzymes for Drug Synthesis Market Size, by Recombinant, 2017-2032 (USD Million)
TABLE 305. United States Enzymes for Drug Synthesis Market Size, by Process Type, 2017-2032 (USD Million)
TABLE 306. United States Enzymes for Drug Synthesis Market Size, by Immobilized Enzyme, 2017-2032 (USD Million)
TABLE 307. United States Enzymes for Drug Synthesis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 308. United States Enzymes for Drug Synthesis Market Size, by Application, 2017-2032 (USD Million)
TABLE 309. United States Enzymes for Drug Synthesis Market Size, by End User, 2017-2032 (USD Million)
TABLE 310. Canada Enzymes for Drug Synthesis Market Size, 2017-2032 (USD Million)
TABLE 311. Canada Enzymes for Drug Synthesis Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 312. Canada Enzymes for Drug Synthesis Market Size, by Hydrolase, 2017-2032 (USD Million)
TABLE 313. Canada Enzymes for Drug Synthesis Market Size, by Protease, 2017-2032 (USD Million)
TABLE 314. Canada Enzymes for Drug Synthesis Market Size, by Oxidoreductase, 2017-2032 (USD Million)
TABLE 315. Canada Enzymes for Drug Synthesis Market Size, by Transferase, 2017-2032 (USD Million)
TABLE 316. Canada Enzymes for Drug Synthesis Market Size, by Source, 2017-2032 (USD Million)
TABLE 317. Canada Enzymes for Drug Synthesis Market Size, by Recombinant, 2017-2032 (USD Million)
TABLE 318. Canada Enzymes for Drug Synthesis Market Size, by Process Type, 2017-2032 (USD Million)
TABLE 319. Canada Enzymes for Drug Synthesis Market Size, by Immobilized Enzyme, 2017-2032 (USD Million)
TABLE 320. Canada Enzymes for Drug Synthesis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 321. Canada Enzymes for Drug Synthesis Market Size, by Application, 2017-2032 (USD Million)
TABLE 322. Canada Enzymes for Drug Synthesis Market Size, by End User, 2017-2032 (USD Million)
TABLE 323. Mexico Enzymes for Drug Synthesis Market Size, 2017-2032 (USD Million)
TABLE 324. Mexico Enzymes for Drug Synthesis Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 325. Mexico Enzymes for Drug Synthesis Market Size, by Hydrolase, 2017-2032 (USD Million)
TABLE 326. Mexico Enzymes for Drug Synthesis Market Size, by Protease, 2017-2032 (USD Million)
TABLE 327. Mexico Enzymes for Drug Synthesis Market Size, by Oxidoreductase, 2017-2032 (USD Million)
TABLE 328. Mexico Enzymes for Drug Synthesis Market Size, by Transferase, 2017-2032 (USD Million)
TABLE 329. Mexico Enzymes for Drug Synthesis Market Size, by Source, 2017-2032 (USD Million)
TABLE 330. Mexico Enzymes for Drug Synthesis Market Size, by Recombinant, 2017-2032 (USD Million)
TABLE 331. Mexico Enzymes for Drug Synthesis Market Size, by Process Type, 2017-2032 (USD Million)
TABLE 332. Mexico Enzymes for Drug Synthesis Market Size, by Immobilized Enzyme, 2017-2032 (USD Million)
TABLE 333. Mexico Enzymes for Drug Synthesis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 334. Mexico Enzymes for Drug Synthesis Market Size, by Application, 2017-2032 (USD Million)
TABLE 335. Mexico Enzymes for Drug Synthesis Market Size, by End User, 2017-2032 (USD Million)
TABLE 336. Brazil Enzymes for Drug Synthesis Market Size, 2017-2032 (USD Million)
TABLE 337. Brazil Enzymes for Drug Synthesis Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 338. Brazil Enzymes for Drug Synthesis Market Size, by Hydrolase, 2017-2032 (USD Million)
TABLE 339. Brazil Enzymes for Drug Synthesis Market Size, by Protease, 2017-2032 (USD Million)
TABLE 340. Brazil Enzymes for Drug Synthesis Market Size, by Oxidoreductase, 2017-2032 (USD Million)
TABLE 341. Brazil Enzymes for Drug Synthesis Market Size, by Transferase, 2017-2032 (USD Million)
TABLE 342. Brazil Enzymes for Drug Synthesis Market Size, by Source, 2017-2032 (USD Million)
TABLE 343. Brazil Enzymes for Drug Synthesis Market Size, by Recombinant, 2017-2032 (USD Million)
TABLE 344. Brazil Enzymes for Drug Synthesis Market Size, by Process Type, 2017-2032 (USD Million)
TABLE 345. Brazil Enzymes for Drug Synthesis Market Size, by Immobilized Enzyme, 2017-2032 (USD Million)
TABLE 346. Brazil Enzymes for Drug Synthesis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 347. Brazil Enzymes for Drug Synthesis Market Size, by Application, 2017-2032 (USD Million)
TABLE 348. Brazil Enzymes for Drug Synthesis Market Size, by End User, 2017-2032 (USD Million)
TABLE 349. United Kingdom Enzymes for Drug Synthesis Market Size, 2017-2032 (USD Million)
TABLE 350. United Kingdom Enzymes for Drug Synthesis Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 351. United Kingdom Enzymes for Drug Synthesis Market Size, by Hydrolase, 2017-2032 (USD Million)
TABLE 352. United Kingdom Enzymes for Drug Synthesis Market Size, by Protease, 2017-2032 (USD Million)
TABLE 353. United Kingdom Enzymes for Drug Synthesis Market Size, by Oxidoreductase, 2017-2032 (USD Million)
TABLE 354. United Kingdom Enzymes for Drug Synthesis Market Size, by Transferase, 2017-2032 (USD Million)
TABLE 355. United Kingdom Enzymes for Drug Synthesis Market Size, by Source, 2017-2032 (USD Million)
TABLE 356. United Kingdom Enzymes for Drug Synthesis Market Size, by Recombinant, 2017-20

Companies Mentioned

  • AB Enzymes GmbH
  • ALLOYZMES Pte Ltd.
  • Amano Enzyme Inc.
  • BASF SE
  • Biomatter Inc.
  • Codexis, Inc.
  • DuPont de Nemours, Inc.
  • Evonik Industries AG
  • GenScript Biotech Corporation
  • Lonza Group AG
  • Novozymes A/S
  • Promega Corporation
  • Royal DSM N.V.
  • Takara Bio Inc.

Related Topics

Related Reports

Chlorosulfonyl Isocyanate (CSI) Market Analysis: Strategic Battery Electrolyte Trends, Pharmaceutical Synthesis, and Industry Forecast (2026-2031) - Product Image

Chlorosulfonyl Isocyanate (CSI) Market Analysis: Strategic Battery Electrolyte Trends, Pharmaceutical Synthesis, and Industry Forecast (2026-2031)

  • Report
  • 77 Pages
  • Global
From
EMB (CAS No. 925-90-6) Market Analysis: Strategic Supply Chain, Pharmaceutical Synthesis Applications, and Regional Forecasts - Product Image

EMB (CAS No. 925-90-6) Market Analysis: Strategic Supply Chain, Pharmaceutical Synthesis Applications, and Regional Forecasts

  • Report
  • 95 Pages
  • Global
From
Enzymes for Antibiotic Synthesis Market - Global Forecast 2026-2032 - Product Image

Enzymes for Antibiotic Synthesis Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Healthcare Specialty Enzymes Market - Global Forecast 2026-2032 - Product Image

Healthcare Specialty Enzymes Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Enzymes Market Size, Share, Trends and Forecast by Type, Source, Reaction Type, Application, and Region, 2026-2034 - Product Image

Enzymes Market Size, Share, Trends and Forecast by Type, Source, Reaction Type, Application, and Region, 2026-2034

  • Report
  • 146 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.